{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:25:58Z","timestamp":1777947958615,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.aohep.2024.101755","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T19:56:45Z","timestamp":1733169405000},"page":"101755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["HLA-G liver expression in chronically HIV\/hepatitis C-coinfected individuals."],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8232-5375","authenticated-orcid":false,"given":"Fernando Crivelenti","family":"Vilar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Donadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedito Ant\u00f4nio Lopes","family":"da Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janaina Cristiana de Oliveira Crispim","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Let\u00edcia Gomide Zanin","family":"Borducchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo de Carvalho","family":"Santana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.aohep.2024.101755_bib0001","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1001\/archinte.166.15.1632","article-title":"Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study","volume":"166","author":"Weber","year":"2006","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.aohep.2024.101755_bib0002","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1086\/432762","article-title":"Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy","volume":"192","author":"Rockstroh","year":"2005","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.aohep.2024.101755_bib0003","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/COH.0b013e32834bd365","article-title":"HIV\/hepatitis C coinfection natural history and disease progression","volume":"6","author":"Hernandez","year":"2011","journal-title":"Curr Opin HIV AIDS"},{"issue":"4","key":"10.1016\/j.aohep.2024.101755_bib0004","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1365-2567.2012.03593.x","article-title":"The multi-faceted nature of HLA class I dimer molecules","volume":"136","author":"Campbell","year":"2012","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.aohep.2024.101755_bib0005","first-page":"91","article-title":"Modulation of HLA expression in human cytomegalovirus immune evasion","volume":"4","author":"Lin","year":"2007","journal-title":"Cell Mol Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.aohep.2024.101755_bib0006","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1399-0039.2006.763_6.x","article-title":"Functions of HLA-G in the immune system","volume":"69","author":"Favier","year":"2007","journal-title":"Tissue Antigens"},{"issue":"3","key":"10.1016\/j.aohep.2024.101755_bib0007","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.it.2007.11.005","article-title":"HLA-G: from biology to clinical benefits","volume":"29","author":"Carosella","year":"2008","journal-title":"Trends Immunol"},{"issue":"3","key":"10.1016\/j.aohep.2024.101755_bib0008","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1399-0039.2006.00757.x","article-title":"Research on HLA-G: an update","volume":"69","author":"Favier","year":"2007","journal-title":"Tissue Antigens"},{"issue":"11","key":"10.1016\/j.aohep.2024.101755_bib0009","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1097\/QAD.0b013e32832d0825","article-title":"Persistence of high levels of blood soluble human leukocyte antigen-G is associated with rapid progression of HIV infection","volume":"23","author":"Lajoie","year":"2009","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.aohep.2024.101755_bib0010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1365-2893.2010.01286.x","article-title":"Liver HLA-G expression is associated with multiple clinical and histopathological forms of chronic hepatitis B virus infection","volume":"18","author":"Souto","year":"2011","journal-title":"J Viral Hepat"},{"issue":"3","key":"10.1016\/j.aohep.2024.101755_bib0011","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.humimm.2011.12.004","article-title":"Upregulation of soluble and membrane-bound human leukocyte antigen G expression is primarily observed in the milder histopathological stages of chronic hepatitis C virus infection","volume":"73","author":"de Oliveira Crispim","year":"2012","journal-title":"Hum Immunol"},{"issue":"6","key":"10.1016\/j.aohep.2024.101755_bib0012","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep.1840190629","article-title":"Classification of chronic hepatitis: diagnosis, grading and staging","volume":"19","author":"Desmet","year":"1994","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.aohep.2024.101755_bib0013","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1600-0676.1989.tb00378.x","article-title":"Hepatocellular transferrin receptor expression in secondary siderosis","volume":"9","author":"Sciot","year":"1989","journal-title":"Liver"},{"issue":"3","key":"10.1016\/j.aohep.2024.101755_bib0014","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jhep.2003.11.004","article-title":"The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients","volume":"40","author":"Patton","year":"2004","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2024.101755_bib0015","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.trim.2007.10.010","article-title":"Human leukocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection","volume":"18","author":"Crispim","year":"2008","journal-title":"Transpl Immunol"},{"issue":"5685","key":"10.1016\/j.aohep.2024.101755_bib0016","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.1097670","article-title":"HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection","volume":"305","author":"Khakoo","year":"2004","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.aohep.2024.101755_bib0017","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1097\/QAD.0b013e32833a2a32","article-title":"Hepatitis C infection in HIV-1 natural viral suppressors","volume":"24","author":"Sajadi","year":"2010","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.aohep.2024.101755_bib0018","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/hep.23679","article-title":"Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: implications for the pathogenesis of HIV\/hepatitis C virus-induced liver fibrosis","volume":"52","author":"Tuyama","year":"2010","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.aohep.2024.101755_bib0019","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1182\/blood-2005-03-1243","article-title":"CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL\/DR5-mediated apoptosis","volume":"106","author":"Herbeuval","year":"2005","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.aohep.2024.101755_bib0020","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.humimm.2004.07.239","article-title":"The short cytoplasmic tail of HLA-G determines its resistance to HIV-1 Nef-mediated cell surface downregulation","volume":"65","author":"Pizzato","year":"2004","journal-title":"Hum Immunol"},{"issue":"3","key":"10.1016\/j.aohep.2024.101755_bib0021","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00002030-200202150-00005","article-title":"Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule","volume":"16","author":"Lozano","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.aohep.2024.101755_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108482","article-title":"HLA-G liver expression and HLA-G extended haplotypes are associated with chronic hepatitis C in HIV-negative and HIV-coinfected patients","volume":"217","author":"Bertol","year":"2020","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.aohep.2024.101755_bib0023","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jhep.2013.09.006","article-title":"Expression of HLA-G by mast cells is associated with hepatitis C virus-induced liver fibrosis","volume":"60","author":"Amiot","year":"2014","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.aohep.2024.101755_bib0024","doi-asserted-by":"crossref","first-page":"e25185","DOI":"10.1371\/journal.pone.0025185","article-title":"High level of soluble HLA-G in the female genital tract of Beninese commercial sex workers is associated with HIV-1 infection","volume":"6","author":"Thibodeau","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.aohep.2024.101755_bib0025","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10238-015-0399-5","article-title":"Behavior of soluble HLA-A, -B, -C and HLA-G molecules in patients with chronic hepatitis C virus infection undergoing pegylated interferon-alpha and ribavirin treatment: potential role as markers of response to antiviral therapy","volume":"17","author":"Murdaca","year":"2017","journal-title":"Clin Exp Med"},{"issue":"8","key":"10.1016\/j.aohep.2024.101755_bib0026","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1111\/liv.14537","article-title":"Global real-world evidence of sofosbuvir\/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts","volume":"40","author":"Mangia","year":"2020","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.aohep.2024.101755_bib0027","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jhep.2016.04.008","article-title":"Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy","volume":"65","author":"Reig","year":"2016","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2024.101755_bib0028","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1053\/j.gastro.2016.12.021","article-title":"Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis","volume":"152","author":"Ravi","year":"2017","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.aohep.2024.101755_bib0029","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2016.06.015","article-title":"Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals","volume":"65","author":"Conti","year":"2016","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.aohep.2024.101755_bib0030","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1053\/j.gastro.2018.07.015","article-title":"Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs","volume":"155","author":"Nahon","year":"2018","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.aohep.2024.101755_bib0031","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jhep.2018.09.029","article-title":"Impact of direct-acting antivirals on early recurrence of HCV-related HCC: Comparison with interferon-based therapy","volume":"70","author":"Nishibatake Kinoshita","year":"2019","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.aohep.2024.101755_bib0032","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/liv.13456","article-title":"Direct-acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C","volume":"37","author":"Virlogeux","year":"2017","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.aohep.2024.101755_bib0033","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1053\/j.gastro.2019.01.027","article-title":"Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study","volume":"156","author":"Singal","year":"2019","journal-title":"Gastroenterology"},{"issue":"10179","key":"10.1016\/j.aohep.2024.101755_bib0034","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(18)32111-1","article-title":"Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study","volume":"393","author":"Carrat","year":"2019","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.aohep.2024.101755_bib0035","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/liv.14041","article-title":"Treatment with direct-acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma","volume":"39","author":"Pinero","year":"2019","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.aohep.2024.101755_bib0036","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/liv.14226","article-title":"Intrahepatic immune changes after hepatitis c virus eradication by direct-acting antiviral therapy","volume":"40","author":"Amaddeo","year":"2020","journal-title":"Liver Int"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268124005386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268124005386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T04:36:55Z","timestamp":1777783015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268124005386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1665268124005386"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101755","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HLA-G liver expression in chronically HIV\/hepatitis C-coinfected individuals.","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101755","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101755"}}